Status:
UNKNOWN
Effects of Technique on the Local Anesthetic Dose Required for Interscalene Brachial Plexus Block
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Arthroscopic Shoulder Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Interscalene brachial plexus block (ISBPB) is a common nerve block given to patients who are undergoing shoulder surgery. This block has a low, but still significant, rate of complications. Reducing t...
Detailed Description
This will be a randomized, single-blind, up-down sequential allocation study. Patients will be randomly assigned to one of two groups, and receive either an ultrasound-guided or nerve-stimulator guide...
Eligibility Criteria
Inclusion
- Patients receiving interscalene brachial plexus block for arthroscopic shoulder surgery
Exclusion
- ASA \>III, and body mass index (BMI) \>35, pre-existing chronic obstructive pulmonary disease (COPD), unstable asthma, psychiatric history, renal or hepatic impairment, allergy to ropivacaine, and opioid tolerance (\>30 mg oral morphine or equivalent per day).
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00731146
Start Date
August 1 2008
End Date
July 1 2009
Last Update
August 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5